[TREATMENT OF PSYCHIC DISORDERS OF CEREBRAL ATHEROSCLEROSIS. DIAGNOSTIC, NOSOLOGIC AND PATHOGENIC ASPECTS].
D001786:Blood Glucose; D002545:Brain Ischemia; D002560:Cerebrovascular Circulation; D002784:Cholesterol / Q000097:blood*; D003704:Dementia; D003863:Depression; D004358:Drug Therapy; D006439:Hemodynamics; D006801:Humans; D007361:Intelligence Tests; D002537:Intracranial Arteriosclerosis; D002546:Ischemic Attack, Transient; D001523:Mental Disorders; D008659:Metabolic Diseases; D011613:Psychotherapy; D011618:Psychotic Disorders; D013881:Thioridazine; D014511:Uremia; D014665:Vasodilator Agents
D001786:Blood Glucose; D014665:Vasodilator Agents; D002784:Cholesterol; D013881:Thioridazine
BLOOD CHOLESTEROL; BLOOD SUGAR; CEREBRAL ARTERIOSCLEROSIS; CEREBRAL ISCHEMIA, TRANSIENT; CEREBROVASCULAR CIRCULATION; DEPRESSION; DRUG THERAPY; HEMODYNAMICS; INTELLIGENCE TESTS; MENTAL DISORDERS; METABOLIC DISEASES; PSYCHOSES, PRESENILE; PSYCHOSES, SENILE; PSYCHOTHERAPY; THIORIDAZINE; UREMIA; VASODILATOR AGENTS
TRAITEMENT DES TROUBLES PSYCHIQUES DE L'ATH'EROSCLEROSE C'ER'EBRALE. SES BASES DIAGNOSTIQUES, NOSOLOGIQUES ET PATHOGENIQUES.